EULAR’s COVID-19 recommendations offer no surprises
June 11, 2020
The provisional recommendations cover four themes: general measures and preventing SARS-CoV-2 infection, managing patients without COVID-19 and those with the infection, and preventing COVID-19 lookalikes.
Age leads COVID-19 hospitalization risk factors in RMDs
June 10, 2020
Glucocorticoid use, cardiovascular comorbidity, and male gender were also found to increase the risk of hospitalization from COVID-19 in inflammatory rheumatic diseases.
Most rheumatology drugs don’t increase COVID-19 hospitalization risk
June 4, 2020
“These results provide, for the first time, information about the outcome of COVID-19 in patients with rheumatic and musculoskeletal diseases.”
TNF inhibitors may dampen COVID-19 severity
May 19, 2020
New findings from the COVID-19 Global Rheumatology Alliance Registry.
Advice on treating rheumatic diseases from a COVID-19 epicenter
May 13, 2020
Hospital for Special Surgery rheumatologists discuss their approach to caring for patients with rheumatic diseases within their practice during the COVID-19 pandemic.
ACR gives guidance on rheumatic disease management during pandemic
May 12, 2020
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be stopped or held.
Case series suggests biologics, JAK inhibitors safe during pandemic
May 1, 2020
Investigators saw no increase in hospitalizations versus the general population in New York City.
Latest data on COVID-19 patients with rheumatic diseases revealed in registry
April 23, 2020
Data for a total of 583 COVID-19 patients have now been made available.
‘We’re in great distress here,’ infusion center CMO says
April 10, 2020
Thrivewell is also deploying a mobile infusion unit to recovered COVID-19 patients who require an infusion for their autoimmune disease.
Treatment for RA, SpA may not affect COVID-19 severity
April 8, 2020
A small study in Italy saw no apparent worsening of COVID-19 symptoms among people treated for RA or spondyloarthritis.